#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Action Plan

The data-driven R&D Autobahn to Cures

Science Pool

Evotec's new scientific content hub

Jobs

What you can contribute

IR & ESG

How you can participate

Highlights

Evotec Capital Markets Day - Paradigm Shift in Biologics

2 November 2022 in Redmond / Seattle

Click here for webcast recording

DDup 13

PanHunter: Evotec's next-generation multi-omics data analysis platform

Just - Evotec Biologics' J.POD® wins CPhI Pharma Award 2022

DDup 12

Evotec`s 3D cell model platform

A Spotlight on Aging

Innovative webinar series

Register here

News View all news

Evotec's partner Exscientia receives first CTA approval for Phase I/II trial of EXS-21546

Oxford, UK, 28 Nov 2022

Evotec’s partner Exscientia plc today announced clinical trial application (“CTA”) approval of a Phase I/II trial of...

Read more

Evotec SE reports results for the first nine months 2022 and provides corporate update

Hamburg, Germany, 09 Nov 2022

Evotec SE today announced the financial results and corporate updates for the first nine months 2022. Group revenues increased by...

Read more

IR & ESG Events View all events

5 December2022

Berenberg European Conference Venue: Surrey, London
Organisers: Berenberg

Company Presentation

Download our Company Presentation

November 2022

Download

TOP